Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip

Humacyte Inc. (NASDAQ: HUMA) Listen to this Section


$6.48
+0.3400 ( +5.54% ) 3.0M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Market Data


Open


$6.48

Previous close


$6.14

Volume


3.0M

Market cap


$773.40M

Day range


$6.13 - $6.69

52 week range


$1.96 - $9.97

Insider Ownership Transactions

Total Amount Purchased: -1,882,126.00 | $ -12,196,176.48

Date Type Amount Purchased Purchaser
2024-06-03 Sale -61941.00 Prichard Heather Ledbetter
2024-05-21 Buy 4015.00 Wallace Max N.
2024-05-21 Sale -600.00 Green Charles Bruce
2024-05-20 Sale -600.00 Green Charles Bruce
2024-05-15 Buy 50000.00 Binder Gordon M
2023-12-12 Sale -276000.00 Scheessele William John
2023-12-12 Sale -283000.00 Parikh Shamik J
2023-12-12 Sale -210000.00 Cao Yang
2023-12-12 Sale -301000.00 Sander Dale A.
2023-12-12 Sale -803000.00 Dougan Brady W

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.